BMC Urology works with with Cochrane Urology in providing our authors with expert advice on systematic reviews and meta-analyses
Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer
To explore the mechanisms of radiotherapy resistance and search for prognostic biomarkers for prostate cancer.